EQIPX Fees and Costs — Equinox IPM Systematic Macro Fund, Class I

Data updated: 2020-03-25

The net expense ratio is 1.89% (2.09% before fee waivers). There are no sales loads or redemption fees. Portfolio turnover was 54%.

EQIPX Fees and Expenses

Annual operating expenses and sales charges of EQIPX. Prospectus, as of October 31, 2019.

Annual operating expenses
Management fee1.68%
12b-1 fee—
Other expenses—
Gross expense ratio2.09%
Fee waiver−0.20%
Net expense ratio1.89%
Sales charges
Max front load—
Max deferred load—
Redemption fee0.00%
Expense limitation in place (N-CEN)Yes
Fees waived or reduced during the yearYes
Waived fees subject to recoupmentYes

EQIPX Costs Over Time

On $10,000 invested in EQIPX, assuming 5% a year before costs, total costs come to $1,161 over 5 years, cutting the return by 1.98% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).

$10,000 investedSell after 1 yearSell after 3 yearsSell after 5 years
Value before costs$10,500$11,576$12,763
Fund expenses (net expense ratio 1.89%)$198$613$1,054
Lost growth on money paid in costs$0$31$107
Total costs$198$644$1,161
Value after costs$10,302$10,932$11,601
Impact on return, per year1.98%1.98%1.98%

EQIPX Trading Costs

Brokerage costs reported on SEC Form N-CEN for the fiscal year ending January 17, 2020.

  • Explicit cost rate (commissions ÷ average net assets): —
  • Total broker commissions: —
  • Bought from dealers (principal trades, not a cost): $382.2M
  • Portfolio turnover (prospectus): 54%
  • Securities lending: none during the year

EQIPX Dealer Counterparties

Securities bought directly from dealers (principal trades).

BrokerAmountShare
U.S. Bank N.A.$358.2M93.72%
Morgan Stanley$24.0M6.28%

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.